Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Nippon India Nifty Pharma ETF | ANGEL ONE NIFTY TOTAL MARKET ETF | |
|---|---|---|
| Category | Equity ETFs | Equity ETFs |
| Plan | Direct | Direct |
| Fund house | Nippon India | Angel One |
| NAV | ₹29.1863 | ₹12.2935 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 5.4 years | 1.7 years |
| Expense ratio | 0.2% | 0.3% |
| Stars | Not rated | Not rated |
| Growth Score | — | — |
Returns
| Nippon India Nifty Pharma ETF | ANGEL ONE NIFTY TOTAL MARKET ETF | |
|---|---|---|
| 1 month | +10.82% | +8.90% |
| 3 months | +7.43% | +2.79% |
| 6 months | +14.54% | +7.36% |
| YTD | +25.40% | +1.96% |
| 1 year | +25.57% | +1.37% |
| 3 years (CAGR) | +22.02% | — |
| 5 years (CAGR) | +16.60% | — |
| 10 years (CAGR) | — | — |
| Since launch | +14.02% | +11.56% |
Risk
| Nippon India Nifty Pharma ETF | ANGEL ONE NIFTY TOTAL MARKET ETF | |
|---|---|---|
| Volatility | 15.0% | — |
| Downside volatility | 9.0% | — |
| Sharpe | 1.04 | — |
| Sortino | 1.72 | — |
| Calmar | 1.33 | — |
| Return / risk | 1.47 | — |
| Deepest fall | −20.98% | −14.82% |
| Days to recover | 136 | 226 |
| Below its high | −1.75% | +0.00% |
Against benchmark
| Nippon India Nifty Pharma ETF | ANGEL ONE NIFTY TOTAL MARKET ETF | |
|---|---|---|
| Alpha | +0.00% | — |
| Beta | 1.00 | — |
| R² | 100.0% | — |
| Up capture | 100.0% | — |
| Down capture | 100.0% | — |
| Tracking error | 0.0% | — |
| Information ratio | — | — |
| Treynor | 0.14 | — |
Consistency
| Nippon India Nifty Pharma ETF | ANGEL ONE NIFTY TOTAL MARKET ETF | |
|---|---|---|
| Best 1-year | +65.21% | +12.36% |
| Middle 1-year | +13.46% | +0.70% |
| Worst 1-year | −15.30% | −8.79% |
| 1-year periods with a loss | 25.8% | 38.6% |
| Middle 3-year | +20.51% | — |
| Positive months | 61.1% | — |
| Best day | +3.64% | +3.95% |
| Worst day | −4.03% | −3.40% |
| Worst 5% day | −1.62% | −1.42% |
| Positive days | 54.4% | 52.8% |
| NAVs a year | 248 | 247 |
SIP of ₹10,000 a month
| Nippon India Nifty Pharma ETF | ANGEL ONE NIFTY TOTAL MARKET ETF | |
|---|---|---|
| 5-year XIRR | +20.60% | — |
| 5-year value | ₹10,11,738 | — |
| 3-year XIRR | +19.58% | — |
| 1-year XIRR | +34.31% | +9.69% |
Holdings overlap i
| Nippon India Nifty Pharma ETF | ANGEL ONE NIFTY TOTAL MARKET ETF | |
|---|---|---|
| Nippon India Nifty Pharma ETF | — | 5% |
| ANGEL ONE NIFTY TOTAL MARKET ETF | 5% | — |
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Held by all of them
| Stock | Nippon India Nifty Pharma ETF | ANGEL ONE NIFTY TOTAL MARKET ETF |
|---|---|---|
| Sun Pharmaceutical Industries Limited | 18.61% | 0.95% |
| Divi's Laboratories Limited | 12.28% | 0.63% |
| Laurus Labs Limited | 9.26% | 0.47% |
| Dr. Reddy's Laboratories Limited | 8.15% | 0.42% |
| Cipla Limited | 7.67% | 0.39% |
| Torrent Pharmaceuticals Limited | 6.71% | 0.34% |
| Lupin Limited | 4.83% | 0.25% |
| Aurobindo Pharma Limited | 4.59% | 0.23% |
| Glenmark Pharmaceuticals Limited | 3.42% | 0.17% |
| Zydus Lifesciences Limited | 3.05% | 0.16% |
| Alkem Laboratories Limited | 3.05% | 0.16% |
| Mankind Pharma Limited | 2.79% | 0.14% |
| IPCA Laboratories Limited | 2.65% | 0.13% |
| Gland Pharma Limited | 2.44% | 0.12% |
| Biocon Limited | 2.42% | 0.12% |
| Sai Life Sciences Limited | 2.13% | 0.11% |
| Ajanta Pharma Limited | 1.58% | 0.08% |
| Wockhardt Limited | 1.55% | 0.08% |
| Piramal Pharma Limited | 1.47% | 0.07% |
| Abbott India Limited | 1.32% | 0.07% |
Sectors and company size
| Nippon India Nifty Pharma ETF | ANGEL ONE NIFTY TOTAL MARKET ETF | |
|---|---|---|
| Large companies | 45.3% | 65.5% |
| Mid companies | 47.1% | 19.7% |
| Small companies | 7.6% | 14.7% |
| Top 10 holdings | 78.6% | 28.5% |
| Largest sector | Pharmaceuticals & Biotechnology 100% | Banks 19% |